Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.

Chengrong ZhangGuoshuang ShenHuihui LiYuanfang XinMingqiang ShiYonghui ZhengMiaozhou WangZhen LiuYi ZhaoFuxing ZhaoDengfeng RenJiuda Zhao

Published in: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry (2023)

The incidence of ONJ caused by denosumab and bisphosphonates is low, the dose of the drug and the type of cancer have certain influence on ONJ. Therefore, clinicians should use the drug reasonably to improve the quality of life of patients.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
risk factors
bone mineral density
chronic kidney disease
palliative care
lymph node metastasis
prognostic factors
childhood cancer
emergency department
peritoneal dialysis
young adults
patient reported